The simultaneous measurement of quaternary mixture in over-the-counter cold medications using sequential spectrophotometric resolution approach enhanced with in-lab sample enrichment.

A sequential spectrophotometric resolution technique (SSRT) was developed in this study without the use of systematic separation procedures to determine drug of a quaternary combination; caffeine (CAF), pseudoephedrine (PSE), doxylamine succinate (DOX), and paracetamol (PAR). Their presence in a tablet with a gap ratio of 3:3:1:150, respectively, and their overlapping spectra with low absorptivities make their resolution and determination impossible without prior separation. successive ratio subtraction technique (SRST) and constant multiplication method were used to solve these problems. Furthermore, an in-lab sample enrichment technique was applied to increase minor components concentration and consequently their absorbanses (CAF, PSE, and DOX). The D0 absorption spectra were generated by successive ratios followed by subtraction and multiplication of the constants. The maximum absorbances of the drugs tested, namely (CAF, PSE, DOX and PAR) were measured at wavelengths of 272.0, 257.0, 260.0, and 248.0 nm, respectively. The limits of detection (LOD) and limits of quantification (LOQ) were 0.021, 0.124, 0.186, 0.137 and 0.070, 0.414, 0.621, 0.456 (µg/mL), respectively. The linearitiy ranges (µg/mL) were 1.0-22.0, 1.0-24.0, 10.0-90.0 and 1.0-15.0 for CAF, PSE, DOX, and PAR, respectively. The International Conference on Harmonization (ICH) guidelines were applied for method validation, and the results obtained were within the limited parameters. The finding results were compared to official and/or published analytical methods to determine the procedure's reliability. It was noted that there was no actual difference in accuracy and precision between both meyhods. The proposed technique is sensitive, selective and economic;so it can be applied to the simultaneous analysis of these drugs in their commercial tablets and/or in quality-control laboratories.

Green electrochemical and chromatographic quantifications of the extremolyte ectoine in halophilic bacterial cultures and related pharmaceutical preparations.

The realistic implementation of electrochemistry into bacterial biosynthesis monitoring programs has always been a challenging task. In this study, two simple, rapid, selective, and sensitive potentiometric sensors were developed and optimized for quantitative analysis of the extremolyte / osmoprotector ectoine (ECT) in halophilic bacterial cultures and also in its related pharmaceutical products. The developed sensors were a Polyvinyl chloride membrane sensor (ECT-PVC) and a coated graphite sensor (ECT-CG). They were established based on the ion association complex of ectoine cation with phosphotungstic acid (ECT-PTA) counter anion as ion exchange site using dioctyl-phthalate (DOP) as a solvent mediator or plasticizer. The sensors exhibited fast, stable, selective, and linear Nernstian responses over a broad range of concentrations ranging from 1 × 10-5 to 1 × 10-2 M of the studied drug. The developed sensors were optimized and cross-validated with a proposed HPLC method according to ICH guidelines. The proposed methods were successfully employed to quantify the studied drug in three different types of halophilic bacterial cultures and in an ectoine nasal spray pharmaceutical product. The selected bacteria species were Chromohalobacter salexigens, Halobacillus halophilus, and Halomonas elongata. The proposed methods were statistically compared with the reported methods, demonstrating no significant difference with respect to accuracy and precision. Greenness and environmental impact were also evaluated for the proposed procedures, verifying that they were excellent green and eco-friendly analytical methods.

Eco-friendly multivariate curve resolution-alternating least squares and chromatographic quantifications of some veterinary drug residues in pharmaceutical industrial wastewater.

Three eco-friendly and cost-effective analytical methods were developed and optimized for quantitative analysis of some veterinary drug residues in production wastewater samples. The studied drugs were ivermectin, rafoxanide and sulfadimidine. A solid-phase extraction procedure was employed using Bond Elut C18 cartridges, prior to analysis. The first method was a chemometric approach called multivariate curve resolution - alternating least squares (MCR-ALS). A calibration model was developed and several figures of merit (RMSEP, SEP, bias, RE%) were calculated. The second method was a thin layer chromatography followed by densitometric measurements at 245 nm. The separation was performed using silica gel 60 F254 plates and ethyl acetate : acetonitrile : toluene : ammonia (20 : 3 : 2 : 1, by volume) as a developing system. The third method was a high performance liquid chromatographic separation on HiQsil C18 HS column with UV detection at 245 nm. The mobile phase consisted of acetonitrile : methanol : water (60 : 25 : 15, by volume), with a flow rate of 1.5 mL min-1. The proposed methods were validated according to ICH guidelines. The described procedures were applied to quantify the studied drug residues in synthetic and real industrial wastewater samples. The proposed methods were statistically compared with the official and the reported methods, showing no significant difference with respect to accuracy and precision at P = 0.05.

Second derivative synchronous fluorescence determination of avanafil in the presence of its acid-induced degradation product aided by powerful Lean Six Sigma tools augmented with D-optimal design.

In this work, the quantitative determination of an erectile dysfunctional drug avanafil in the presence of its acid-induced degradation product was achieved via the application of a pre-optimized novel spectrofluorimetric method. The fluorescence emission wavelength was recorded at 370 and 407 nm, after being excited at 268 and 271 nm for avanafil and its acid-induced degradation product, respectively. Direct determination of avanafil based on its native fluorescence is restricted because the emission spectra of both components are heavily overlapped. Therefore, to overcome this constraint, a novel second derivative synchronous fluorescence method was evolved to eliminate this overlapping. The ideal determination wavelength was found to be 377 nm. Augmentation of lean six sigma (LSS) with response surface methodology (RSM) play a significant role in the development of robust specifications to ensure quality at the six sigma level with a high level of statistical confidence and targeted performance. All of the experimental conditions were optimized using D-optimal design as a RSM to select the optimal parameters. In addition, this work includes a graphical representation of the relationships between various variables that can greatly affect the results and the intensity of the synchronous fluorescence.

D-optimal design as a useful tool response surface methodology for the optimization of signals from synchronous fluorescence prior to simultaneous determination of avanafil and tadalafil.

A rapid, smart and sensitive first derivative spectrofluorimetric method has been carried out for the simultaneous estimation of avanafil and tadalafil either in their pure form, tablet dosage form or spiked human plasma. The measurements of normal emission spectra or synchronous fluorescence intensity of both drugs show severe overlap which hindered their determination using normal fluorescence or synchronous intensity. Therefore, a highly sensitive first derivative synchronous fluorescence procedure was used to resolve this overlap. The method is based upon measurement of the amplitude of the first derivative of synchronous fluorescence intensity of both drugs at Δλ = 70 nm and at suitable wavelength of 396 nm and 364 nm for avanafil and tadalafil, respectively. Under the optimum conditions, the linear determination ranges are 50-1800 and 5-400 ng mL-1 with a detection limit of 12.93 and 1.46 ng mL-1 for avanafil and tadalafil, respectively. A response surface methodology was used for optimization using D-optimal design which can be used for determination of the exact optimum parameters specifically designed for this method. In addition; it is a good way to graphically clarify the relationship between various experimental variables and the synchronous fluorescence intensity.

A Wireless Head-mountable Device with Tapered Optical Fiber-coupled Laser Diode for Light Delivery in Deep Brain Regions.

Optogenetics sets new experimental paradigms that can reveal cell type-specific contributions on the neural basis of behavior. Since most of the available systems for this purpose are based on approaches that tether animals to a set of cables, recent research activities have been focused on minimizing external factors that can alter animal movements. Current wireless optogenetic systems are based on waveguide-coupled LED and implanted LEDs. However, each configuration separately suffers from significant limitations, such as low coupling efficiency, penetration depth and invasiveness of waveguide-coupled LED, and local heat generated by implanted µLEDs. This work presents a novel wireless head-mountable stimulating system for a wide-volume light delivery. The device couples the output of a semiconductor laser diode (LD) to a tapered optical fiber (TF) on a wireless platform. The LD-TF coupling was engineered by setting up far-field analysis, which allows the full exploitation of the mode division demultiplexing properties of TFs. The output delivered light along the tapered segment is capable of stimulating structures of depths up to ~2mm. TFs are tapered to a gradual taper angle (2° to 10°) that ends with a sharp tip (~500 nm) for smooth insertion and less invasiveness. Thus, the proposed system extends the capabilities of wireless optogenetic by offering a novel solution for wide volume light delivery in deep brain regions.

Dynamic illumination of spatially restricted or large brain volumes via a single tapered optical fiber.

Optogenetics promises precise spatiotemporal control of neural processes using light. However, the spatial extent of illumination within the brain is difficult to control and cannot be adjusted using standard fiber optics. We demonstrate that optical fibers with tapered tips can be used to illuminate either spatially restricted or large brain volumes. Remotely adjusting the light input angle to the fiber varies the light-emitting portion of the taper over several millimeters without movement of the implant. We use this mode to activate dorsal versus ventral striatum of individual mice and reveal different effects of each manipulation on motor behavior. Conversely, injecting light over the full numerical aperture of the fiber results in light emission from the entire taper surface, achieving broader and more efficient optogenetic activation of neurons, compared to standard flat-faced fiber stimulation. Thus, tapered fibers permit focal or broad illumination that can be precisely and dynamically matched to experimental needs.